Country Trust Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9K Sell
126
-15
-11% -$1.98K ﹤0.01% 303
2026
Q1
$19.7K Hold
141
﹤0.01% 255
2025
Q4
$17.3K Hold
141
﹤0.01% 265
2025
Q3
$15.7K Buy
141
+108
+327% +$12.3K ﹤0.01% 285
2025
Q2
$3.66K Buy
+33
New +$3.51K ﹤0.01% 410
2024
Q4
Sell
-3
Closed -$252 381
2024
Q3
$252 Hold
3
﹤0.01% 354
2024
Q2
$206 Buy
+3
New +$200 ﹤0.01% 354
2022
Q1
Sell
-12
Closed -$1K 439
2021
Q4
$1K Hold
12
﹤0.01% 485
2021
Q3
$1K Buy
+12
New +$843 ﹤0.01% 473
2020
Q4
Sell
-12
Closed -$1K 349
2020
Q3
$1K Buy
+12
New +$832 ﹤0.01% 317
2019
Q1
Sell
-8
Closed -$1K 291
2018
Q4
$1K Sell
8
-14
-64% -$979 ﹤0.01% 311
2018
Q3
$2K Buy
+22
New +$1.66K ﹤0.01% 287
2015
Q1
Sell
-100
Closed -$9.43K 222
2014
Q4
$9.43K Buy
+100
New +$10.3K ﹤0.01% 165

Other funds holding GILD

Country Trust Bank's GILD Position: Q2 2026 in Review

Country Trust Bank reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $1.98K and leaving 126 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Country Trust Bank first reported a position in GILD in Q4 2014 and has held it in 13 quarters since. The position peaked at $19.7K in Q1 2026. 932 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Country Trust Bank held 126 shares of Gilead Sciences worth $15.9K as of Q2 2026.
  • Country Trust Bank sold 15 Gilead Sciences shares in Q2 2026, an estimated $1.98K.
  • Gilead Sciences made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #303 holding.
  • Country Trust Bank first reported a position in Gilead Sciences in Q4 2014 and has held it in 13 quarters since.
  • Country Trust Bank's Gilead Sciences position peaked at $19.7K in Q1 2026.
  • 932 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.